Sign up here to receive news updates via email.
-
September 30, 2024 |
Media, News and Updates, Press Releases
BPGbio Receives FDA Rare Pediatric Disease Designation for its Potential Treatment for Primary Coenzyme Q10 Deficiency
read more -
September 25, 2024 |
Media, News and Updates, Press Releases
BPGbio and Joslin Diabetes Center Announce Publication Showing Game Changing Effects of Blue Light in the Reduction of Fat Cells
read more -
September 16, 2024 |
Media, News and Updates, Press Releases
BPGbio Appoints John Beeler as SVP of Business Development
read more -
September 12, 2024 |
Uncategorized, Media, News and Updates, Press Releases
BPGbio Presents Phase 2b BPM31510 Glioblastoma Trial-in-Progress Update and Pioneering Comprehensive Quinomics Assessment at the ESMO Congress 2024
read more -
August 26, 2024 |
Media, News and Updates, Press Releases
BPGbio to Present on its First-in-Class E2-based Approach to Targeted Protein Degradation at 15th Annual Drug Innovation Forum
read more -
August 19, 2024 |
Media, News and Updates, Press Releases
BPGbio to Present Research and Pipeline Advancements on Mitochondrial Medicine at EBEC 2024
read more
